Home LiteratureArticle Details
PMID: 6404830 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

In vitro response of human T cells to Pseudomonas aeruginosa.

Infection and immunity ·Vol. 40 ·No. 2 ·1983-05-00 ·Pages 670-4

Porwoll JM, Gebel HM, Rodey GE, Markham RB

Abstract

Pseudomonas aeruginosa is a gram-negative bacillus that is a major cause of morbidity and mortality in immunosuppressed patients, burn patients, and patients with cystic fibrosis. Although immunity to these bacteria has been associated with serum antibody, more recent evidence suggests that T-cell-mediated immunity may also be important. To evaluate human T-cell responsiveness to these bacteria, the optimal conditions were determined for in vitro proliferation of human peripheral blood lymphocytes and T-lymphocytes to Fisher-Devlin immunotype 1 P. aeruginosa. The proliferative response of normal adult peripheral blood lymphocytes to heat-killed P. aeruginosa was studied in 34 subjects (range, 7,600 to 111,500 net cpm). Analysis of cell subpopulations indicated that T-lymphocytes are the major proliferating cells and that this response is enhanced by the presence of adherent cells. Data from fetal cord lymphocyte responses suggest that the proliferation seen in normal adult lymphocytes is induced by antigenic and not mitogenic stimulation.

MeSH Terms
Age Factors Cells, Cultured Dose-Response Relationship, Immunologic Humans Lymphocyte Activation Lymphocyte Cooperation Macrophages/immunology Pseudomonas aeruginosa/immunology T-Lymphocytes/immunology
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Porwoll J M
Gebel H M
Rodey G E
Markham R B
References (18)
18 references, click to expand
  1. Faecal carriage of Pseudomonas aeruginosa in hospital patients. Possible spread from patient to patient.
    Lancet. 1966 Dec 17;2(7477):1331-4 PMID: 4162795
  2. Contribution of serum and cellular factors in host defense reactions. I. Serumfactors in host resistanc.
    N Engl J Med. 1963 Apr 25;268:933-8 contd PMID: 13965576
  3. Serogroups of Pseudomonas aeruginosa and the immune response of patients with cystic fibrosis.
    J Infect Dis. 1970 Mar;121(3):269-74 PMID: 4984335
  4. Pseudomonas aeruginosa: immune status in patients with cystic fibrosis.
    Infect Immun. 1972 Oct;6(4):628-35 PMID: 4628901
  5. Pulmonary host defenses in rabbits after immunization with Pseudomonas antigens: the interaction of bacteria, antibodies, macrophages, and lymphocytes.
    J Infect Dis. 1974 Nov;130 Suppl(0):S134-42 PMID: 4214195
  6. Cell-mediated immunity in patients with cystic fibrosis.
    Br Med J. 1976 Jan 17;1(6002):120-2 PMID: 813805
  7. Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections.
    Infect Immun. 1977 Dec;18(3):596-602 PMID: 412786
  8. Cellular immunity to bacteria: impairment of in vitro lymphocyte responses to Pseudomonas aeruginosa in cystic fibrosis patients.
    Infect Immun. 1977 Dec;18(3):735-40 PMID: 412789
  9. Lymphocyte responsiveness to Pseudomonas aeruginosa in cystic fibrosis: Relationship to status of pulmonary disease in sibling pairs.
    J Pediatr. 1978 Aug;93(2):201-5 PMID: 97373
  10. Defective cellular immunity to gram-negative bacteria in cystic fibrosis patients.
    Infect Immun. 1979 Feb;23(2):398-402 PMID: 106011
  11. A human lymphocyte mitogen extracted from the extracellular slime layer of Pseudomonas aeruginosa.
    J Infect Dis. 1980 May;141(5):686-8 PMID: 6768815
  12. Mitogenic effects of purified outer membrane proteins from Pseudomonas aeruginosa.
    Infect Immun. 1980 Apr;28(1):178-84 PMID: 6769818
  13. Longitudinal assay of lymphocyte responsiveness in patients with major burns.
    Ann Surg. 1980 Dec;192(6):772-5 PMID: 6449912
  14. Functional characteristics of TG and TnonG cells in a three party MLR.
    J Immunol. 1981 Jan;126(1):118-21 PMID: 6450233
  15. Changes in lymphocyte reactivity to Pseudomonas aeruginosa in hospitalized patients with cystic fibrosis.
    Am Rev Respir Dis. 1981 Jan;123(1):37-41 PMID: 6779685
  16. Safety and immunogenicity of high molecular weight polysaccharide vaccine from immunotype 1 Pseudomonas aeruginosa.
    J Clin Invest. 1982 Feb;69(2):303-8 PMID: 6799548
  17. Induction in mice of cell-mediated immunity to Pseudomonas aeruginosa by high molecular weight polysaccharide and vinblastine.
    J Immunol. 1982 May;128(5):2121-5 PMID: 6174622
  18. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.
    Scand J Clin Lab Invest Suppl. 1968;97:77-89 PMID: 4179068
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1983-05-00
Pages
670-4
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC264907
Subset
IM
Grants
NIAID NIH HHS · AI-153553 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]